Changing seroprevalence of Schistosomiasis japonica in China from 1982 to 2025

Author:

Zhou Yu1ORCID,Zheng Mao2,Gong Yanfeng1,Huang Junhui1,Wang Jiamin1,Xu Ning1,Tong Yixin1,Chen Yue3,Jiang Qingwu1,Cai Yu2,Zhou Yi-Biao1ORCID

Affiliation:

1. Fudan University School of Public Health

2. Hunan Institute for Schistosomiasis Control

3. Ottawa University

Abstract

Abstract Background Schistosomiasis is a tropical disease that seriously threatens human health. Achieving the goal of eliminating schistosomiasis in China by 2030 necessitates precise identification of endemic areas and high-risk populations. This study aimed to figure out the long-term trends of Schistosomiasis japonica seroprevalence in China from 1982 to 2020 and age and spatial variations. Additionally, to forecast the seroprevalence for 2021–2025. Methods Seroprevalence data were collected from literature databases and national schistosomiasis surveillance system. Meta-analysis was conducted to estimate the seroprevalence. Autoregressive integrated moving average model was used to forecast the seroprevalence from 2021 to 2025. Joinpoint model was used to identify changing trend and inflection point. Inverse distance weighted interpolation was used to determine the spatial distribution of seroprevalence in different periods. Results The seroprevalence decreased from 34.8% in 1982 to 2.4% in 2020 in China. ARIMA model predicted that the seroprevalence would stabilize at the level of around 2.0% for 2021–2025. Before 2006, the seroprevalence was higher in the middle age group, and a pattern of increasing with age was observed afterwards. The areas with high seroprevalence existed in Dongting Lake, Poyang Lake, Jianghan Plain, the Anhui branch of the Yangtze River and some localized mountainous regions in Sichuan and Yunnan provinces. Conclusions There was a significant decline in the seroprevalence of Schistosomiasis japonica from 1982 to 2020 in China, and would remain at a low level in 2021–2025. Nevertheless, schistosomiasis has not been eradicated; thus, ongoing monitoring remains crucial, especially in endemic areas and with a particular focus on the elderly.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3